InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding InflaRx N.V. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 27 | 27 | 0 |
| Shares | 16.8M | 18.6M | +1.75M (+10.4%) |
| Value | $13.3M | $24.9M | +$11.6M (+87.3%) |
New holders (8)
Institutions that held InflaRx N.V. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 2,475,000 | $3.32M | 0.00% |
| Marshall Wace, LLP | 307,082 | $411.5K | 0.00% |
| ADAR1 Capital Management, LLC | 159,479 | $213.7K | 0.02% |
| Susquehanna International Group, LLP | 142,055 | $190.4K | 0.00% |
| Citadel Advisors LLC | 102,951 | $138.0K | 0.00% |
| Jane Street Group, LLC | 85,656 | $114.8K | 0.00% |
| Kestra Advisory Services, LLC | 85,000 | $113.9K | 0.00% |
| Group One Trading, L.P. | 8,611 | $11.5K | 0.00% |
Sold out (8)
Institutions that held InflaRx N.V. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Woodline Partners LP | 751,267 | $593.5K |
| DAFNA Capital Management LLC | 200,000 | $158.0K |
| UBS Oconnor LLC | 150,000 | $118.5K |
| Commonwealth Equity Services, LLC | 144,000 | $114.0K |
| Virtu Financial LLC | 60,415 | $48.0K |
| Gsa Capital Partners LLP | 57,951 | $46.0K |
| HRT Financial LP | 43,530 | $34.0K |
| CIBC World Markets Inc. | 25,000 | $19.8K |